Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Felice Vadruccio; Giovanni Biricolti; Leonardo Mendolicchio
   Analisi farmacoeconomica del trattamento di pazienti psicotici cronici con olanzapina, antipsicotici atipici e neurolettici tipici: uno studio regionale
   Farmeconomia e percorsi terapeutici
   
   Felice Vadruccio et al., "Analisi farmacoeconomica del trattamento di pazienti psicotici cronici con olanzapina, antipsicotici atipici e neurolettici tipici: uno studio regionale", Farmeconomia e percorsi terapeutici, 6(2), 2005, pp. 97-104
2. Peuskens, J; De Hert, M; Jones, M
   The clinical value of risperidone and olanzapine: A meta-analysis of efficacy and safety
   INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
   
   J. Peuskens et al., "The clinical value of risperidone and olanzapine: A meta-analysis of efficacy and safety", INT J PSYC, 5(3), 2001, pp. 179-187
3. Diaz, E; Levine, HB; Sullivan, MC; Sernyak, MJ; Hawkins, KA; Cramer, JA; Woods, SW
   Use of the Medication Event Monitoring System to estimate medication compliance in patients with schizophrenia
   JOURNAL OF PSYCHIATRY & NEUROSCIENCE
   
   E. Diaz et al., "Use of the Medication Event Monitoring System to estimate medication compliance in patients with schizophrenia", J PSYCH NEU, 26(4), 2001, pp. 325-329
4. Tempier, R; Pawliuk, N
   Influence of novel and conventional antipsychotic medication on subjectivequality of life
   JOURNAL OF PSYCHIATRY & NEUROSCIENCE
   
   R. Tempier e N. Pawliuk, "Influence of novel and conventional antipsychotic medication on subjectivequality of life", J PSYCH NEU, 26(2), 2001, pp. 131-136
5. Kennedy, A; Jain, S; Vinogradov, S
   Atypical antipsychotics for schizophrenia: Their collective role and comparative profiles
   FORMULARY
   
   A. Kennedy et al., "Atypical antipsychotics for schizophrenia: Their collective role and comparative profiles", FORMULARY, 36(7), 2001, pp. 500
6. Patel, NC; Crismon, ML; Rush, AJ; Frances, A
   Practitioner versus medication-expert opinion on psychiatric pharmacotherapy of mentally retarded patients with mental disorders
   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
   
   N.C. Patel et al., "Practitioner versus medication-expert opinion on psychiatric pharmacotherapy of mentally retarded patients with mental disorders", AM J HEAL S, 58(19), 2001, pp. 1824-1829
7. Schaffner, KF; McGorry, PD
   Preventing severe mental illnesses - new prospects and ethical challenges
   SCHIZOPHRENIA RESEARCH
   
   K.F. Schaffner e P.D. McGorry, "Preventing severe mental illnesses - new prospects and ethical challenges", SCHIZOPHR R, 51(1), 2001, pp. 3-15
8. Peralta, V; Cuesta, MJ
   How many and which are the psychopathological dimensions in schizophrenia?Issues influencing their ascertainment
   SCHIZOPHRENIA RESEARCH
   
   V. Peralta e M.J. Cuesta, "How many and which are the psychopathological dimensions in schizophrenia?Issues influencing their ascertainment", SCHIZOPHR R, 49(3), 2001, pp. 269-285
9. Herbener, ES; Harrow, M
   Longitudinal assessment of negative symptoms in schizophrenia/schizoaffective patients, other psychotic patients, and depressed patients
   SCHIZOPHRENIA BULLETIN
   
   E.S. Herbener e M. Harrow, "Longitudinal assessment of negative symptoms in schizophrenia/schizoaffective patients, other psychotic patients, and depressed patients", SCHIZO BULL, 27(3), 2001, pp. 527-537
10. Mauro Ferrara; Anna Maria Caramadre; Oliviero Bruni; Teresa I.Carratelli
    Compliance nel trattamento integrato delle psicosi in adolescenza
    Psichiatria dell'infanzia e dell'adolescenza
    
    Mauro Ferrara et al., "Compliance nel trattamento integrato delle psicosi in adolescenza", Psichiatria dell'infanzia e dell'adolescenza, 68(2), 2001, pp. 151-162
11. Keck, PE; Reeves, KR; Harrigan, EP
    Ziprasidone in the short-term treatment of patients with schizoaffective disorder: Results from two double-blind, placebo-controlled, multicenter studies
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    
    P.E. Keck et al., "Ziprasidone in the short-term treatment of patients with schizoaffective disorder: Results from two double-blind, placebo-controlled, multicenter studies", J CL PSYCH, 21(1), 2001, pp. 27-35
12. Kasper, S; Rosillon, D; Duchesne, I
    Risperidone Olanzapine Drug Outcomes studies in Schizophrenia (RODOS): efficacy and tolerability results of an international naturalistic study
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    
    S. Kasper et al., "Risperidone Olanzapine Drug Outcomes studies in Schizophrenia (RODOS): efficacy and tolerability results of an international naturalistic study", INT CLIN PS, 16(4), 2001, pp. 179-187
13. Moller, P
    Duration of untreated psychosis: Are we ignoring the mode of initial development? An extensive naturalistic case study of phenomenal continuity in first-episode schizophrenia
    PSYCHOPATHOLOGY
    
    P. Moller, "Duration of untreated psychosis: Are we ignoring the mode of initial development? An extensive naturalistic case study of phenomenal continuity in first-episode schizophrenia", PSYCHOPATH, 34(1), 2001, pp. 8-14
14. Gutkind, D; Ventura, J; Barr, C; Shaner, A; Green, M; Mintz, J
    Factors affecting reliability and confidence of DSM-III-R psychosis-related diagnosis
    PSYCHIATRY RESEARCH
    
    D. Gutkind et al., "Factors affecting reliability and confidence of DSM-III-R psychosis-related diagnosis", PSYCHIAT R, 101(3), 2001, pp. 269-275
15. Tohen, M; Zhang, F; Taylor, CC; Burns, P; Zarate, C; Sanger, T; Tollefson, G
    A meta-analysis of the use of typical antipsychotic agents in bipolar disorder
    JOURNAL OF AFFECTIVE DISORDERS
    
    M. Tohen et al., "A meta-analysis of the use of typical antipsychotic agents in bipolar disorder", J AFFECT D, 65(1), 2001, pp. 85-93
16. Raja, M; Azzoni, A
    Asperger's disorder in the emergency psychiatric setting
    GENERAL HOSPITAL PSYCHIATRY
    
    M. Raja e A. Azzoni, "Asperger's disorder in the emergency psychiatric setting", GEN HOSP PS, 23(5), 2001, pp. 285-293
17. Malla, AK; Norman, RMG; Scholten, DJ; Zirul, S; Kotteda, V
    A comparison of long-term outcome in first-episode schizophrenia followingtreatment with risperidone or a typical antipsychotic
    JOURNAL OF CLINICAL PSYCHIATRY
    
    A.K. Malla et al., "A comparison of long-term outcome in first-episode schizophrenia followingtreatment with risperidone or a typical antipsychotic", J CLIN PSY, 62(3), 2001, pp. 179-184
18. Czekalla, J; Kollack-Walker, S; Beasley, CM
    Cardiac safety parameters of olanzapine: Comparison with other atypical and typical antipsychotics
    JOURNAL OF CLINICAL PSYCHIATRY
    
    J. Czekalla et al., "Cardiac safety parameters of olanzapine: Comparison with other atypical and typical antipsychotics", J CLIN PSY, 62, 2001, pp. 35-40
19. Ruiz, TA; Silva, IH; Miranda, CE
    Clinical and psychometric diagnosis of depression in general medical patients
    REVISTA MEDICA DE CHILE
    
    T.A. Ruiz et al., "Clinical and psychometric diagnosis of depression in general medical patients", REV MED CHI, 129(6), 2001, pp. 627-633
20. Conley, RR; Mahmoud, R
    A randomized double-blind study of risperidone and olanzapine in the treatment of schizophrenia or schizoaffective disorder
    AMERICAN JOURNAL OF PSYCHIATRY
    
    R.R. Conley e R. Mahmoud, "A randomized double-blind study of risperidone and olanzapine in the treatment of schizophrenia or schizoaffective disorder", AM J PSYCHI, 158(5), 2001, pp. 765-774
21. Rubin, NJ; Arceneaux, JM
    Intractable depression or psychosis
    ACTA PSYCHIATRICA SCANDINAVICA
    
    N.J. Rubin e J.M. Arceneaux, "Intractable depression or psychosis", ACT PSYC SC, 104(5), 2001, pp. 402-405
22. Kampman, O; Lehtinen, K; Lassila, V
    The reliability of compliance assessments performed by doctors and patients during neuroleptic treatment: a comparison of compliance ratings
    ACTA PSYCHIATRICA SCANDINAVICA
    
    O. Kampman et al., "The reliability of compliance assessments performed by doctors and patients during neuroleptic treatment: a comparison of compliance ratings", ACT PSYC SC, 104(4), 2001, pp. 299-304
23. Das, SK; Malhotra, S; Basu, D; Malhotra, R
    Testing the stress-vulnerability hypothesis in ICD-10-diagnosed acute and transient psychotic disorders
    ACTA PSYCHIATRICA SCANDINAVICA
    
    S.K. Das et al., "Testing the stress-vulnerability hypothesis in ICD-10-diagnosed acute and transient psychotic disorders", ACT PSYC SC, 104(1), 2001, pp. 56-58
24. Ghaemi, SN; Cherry, EL; Katzow, JA; Goodwin, FK
    Does olanzapine have antidepressant properties? A retrospective preliminary study
    BIPOLAR DISORDERS
    
    S.N. Ghaemi et al., "Does olanzapine have antidepressant properties? A retrospective preliminary study", BIPOL DIS, 2(3), 2000, pp. 196-199
25. Cubells, JF; Kranzler, HR; McCance-Katz, E; Anderson, GM; Malison, RT; Price, LH; Gelernter, J
    A haplotype at the DBH locus, associated with low plasma dopamine beta-hydroxylase activity, also associates with cocaine-induced paranoia
    MOLECULAR PSYCHIATRY
    
    J.F. Cubells et al., "A haplotype at the DBH locus, associated with low plasma dopamine beta-hydroxylase activity, also associates with cocaine-induced paranoia", MOL PSYCHI, 5(1), 2000, pp. 56-63
26. Dunayevich, E; McElroy, SL
    Atypical antipsychotics in the treatment of bipolar disorder - Pharmacological and clinical effects
    CNS DRUGS
    
    E. Dunayevich e S.L. McElroy, "Atypical antipsychotics in the treatment of bipolar disorder - Pharmacological and clinical effects", CNS DRUGS, 13(6), 2000, pp. 433-441
27. Procyshyn, RM; Thompson, D; Tse, G
    Pharmacoeconomics of clozapine, risperidone and olanzapine - A review of the literature
    CNS DRUGS
    
    R.M. Procyshyn et al., "Pharmacoeconomics of clozapine, risperidone and olanzapine - A review of the literature", CNS DRUGS, 13(1), 2000, pp. 47-76
28. Edgell, ET; Andersen, SW; Johnstone, BM; Dulisse, B; Revicki, D; Breier, A
    Olanzapine versus risperidone - A prospective comparison of clinical and economic outcomes in schizophrenia
    PHARMACOECONOMICS
    
    E.T. Edgell et al., "Olanzapine versus risperidone - A prospective comparison of clinical and economic outcomes in schizophrenia", PHARMACOECO, 18(6), 2000, pp. 567-579
29. Almond, S; O'Donnell, O
    Cost analysis of the treatment of schizophrenia in the UK - A simulation model comparing olanzapine, risperidone and haloperidol
    PHARMACOECONOMICS
    
    S. Almond e O. O'Donnell, "Cost analysis of the treatment of schizophrenia in the UK - A simulation model comparing olanzapine, risperidone and haloperidol", PHARMACOECO, 17(4), 2000, pp. 383-389
30. Woods, SW; Ziedonis, DM; Sernyak, MJ; Diaz, E; Rosenheck, RA
    Characteristics of participants and nonparticipants in medication trials for treatment of schizophrenia
    PSYCHIATRIC SERVICES
    
    S.W. Woods et al., "Characteristics of participants and nonparticipants in medication trials for treatment of schizophrenia", PSYCH SERV, 51(1), 2000, pp. 79-84
31. Rabinowitz, J; Lichtenberg, P; Kaplan, Z
    Comparison of cost, dosage and clinical preference for risperidone and olanzapine
    SCHIZOPHRENIA RESEARCH
    
    J. Rabinowitz et al., "Comparison of cost, dosage and clinical preference for risperidone and olanzapine", SCHIZOPHR R, 46(2-3), 2000, pp. 91-96
32. Balestrieri, M; Vampini, C; Bellantuono, C
    Efficacy and safety of novel antipsychotics: A critical review
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    
    M. Balestrieri et al., "Efficacy and safety of novel antipsychotics: A critical review", HUM PSYCHOP, 15(7), 2000, pp. 499-512
33. Naughton, M; Mulrooney, JB; Leonard, BE
    A review of the role of serotonin receptors in psychiatric disorders
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    
    M. Naughton et al., "A review of the role of serotonin receptors in psychiatric disorders", HUM PSYCHOP, 15(6), 2000, pp. 397-415
34. McMurray, L; Steiner, W
    Natural disasters and service delivery to individuals with severe mental illness - Ice Storm 1998
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
    
    L. McMurray e W. Steiner, "Natural disasters and service delivery to individuals with severe mental illness - Ice Storm 1998", CAN J PSY, 45(4), 2000, pp. 383-385
35. Malla, AK; Norman, RMG; Scholten, D
    Predictors of service use and social conditions in patients with psychoticdisorders
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
    
    A.K. Malla et al., "Predictors of service use and social conditions in patients with psychoticdisorders", CAN J PSY, 45(3), 2000, pp. 269-273
36. Wang, PS; West, JC; Tanielian, T; Pincus, HA
    Recent patterns and predictors of antipsychotic medication regimens used to treat schizophrenia and other psychotic disorders
    SCHIZOPHRENIA BULLETIN
    
    P.S. Wang et al., "Recent patterns and predictors of antipsychotic medication regimens used to treat schizophrenia and other psychotic disorders", SCHIZO BULL, 26(2), 2000, pp. 451-457
37. Bleich, A; Moskowits, L
    Post traumatic stress disorder with psychotic features
    CROATIAN MEDICAL JOURNAL
    
    A. Bleich e L. Moskowits, "Post traumatic stress disorder with psychotic features", CROAT MED J, 41(4), 2000, pp. 442-445
38. Duval, F; Mokrani, MC; Crocq, MA; Bailey, PE; Diep, TS; Correa, H; Macher, JP
    Dopaminergic function and the cortisol response to dexamethasone in psychotic depression
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    
    F. Duval et al., "Dopaminergic function and the cortisol response to dexamethasone in psychotic depression", PROG NEUR-P, 24(2), 2000, pp. 207-225
39. Hamilton, SH; Edgell, ET; Revicki, DA; Breier, A
    Functional outcomes in schizophrenia: a comparison of olanzapine and haloperidol in a European sample
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    
    S.H. Hamilton et al., "Functional outcomes in schizophrenia: a comparison of olanzapine and haloperidol in a European sample", INT CLIN PS, 15(5), 2000, pp. 245-255
40. Soares, JC
    Recent advances in the treatment of bipolar mania, depression, mixed states, and rapid cycling
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    
    J.C. Soares, "Recent advances in the treatment of bipolar mania, depression, mixed states, and rapid cycling", INT CLIN PS, 15(4), 2000, pp. 183-196
41. Stewart, DE
    Antidepressant drugs during pregnancy and lactation
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    
    D.E. Stewart, "Antidepressant drugs during pregnancy and lactation", INT CLIN PS, 15, 2000, pp. S19-S24
42. Guan, HJ; Dai, J; Zhu, XZ
    Atypical antipsychotic effects of quetiapine fumarate in animal models
    ACTA PHARMACOLOGICA SINICA
    
    H.J. Guan et al., "Atypical antipsychotic effects of quetiapine fumarate in animal models", ACT PHAR SI, 21(3), 2000, pp. 205-210
43. Keck, PE; Strakowski, SM; McElroy, SL
    The efficacy of atypical antipsychotics in the treatment of depressive symptoms, hostility, and suicidality in patients with schizophrenia
    JOURNAL OF CLINICAL PSYCHIATRY
    
    P.E. Keck et al., "The efficacy of atypical antipsychotics in the treatment of depressive symptoms, hostility, and suicidality in patients with schizophrenia", J CLIN PSY, 61, 2000, pp. 4-9
44. Ghaemi, SN
    New treatments for bipolar disorder: The role of atypical neuroleptic agents
    JOURNAL OF CLINICAL PSYCHIATRY
    
    S.N. Ghaemi, "New treatments for bipolar disorder: The role of atypical neuroleptic agents", J CLIN PSY, 61, 2000, pp. 33-42
45. Tariot, PN; Salzman, C; Yeung, PP; Pultz, J; Rak, IW
    Long-term use of quetiapine in elderly patients with psychotic disorders
    CLINICAL THERAPEUTICS
    
    P.N. Tariot et al., "Long-term use of quetiapine in elderly patients with psychotic disorders", CLIN THER, 22(9), 2000, pp. 1068-1084
46. De Ronchi, D; Faranca, I; Forti, P; Ravaglia, G; Borderi, M; Manfredi, R; Volterra, V
    Development of acute psychotic disorders and HIV-1 infection
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE
    
    D. De Ronchi et al., "Development of acute psychotic disorders and HIV-1 infection", INT J PSY M, 30(2), 2000, pp. 173-183
47. Hilger, E; Kasper, S
    Properties and therapeutic use of atypical antipsychotics: a review
    WIENER KLINISCHE WOCHENSCHRIFT
    
    E. Hilger e S. Kasper, "Properties and therapeutic use of atypical antipsychotics: a review", WIEN KLIN W, 112(24), 2000, pp. 1031-1038
48. Gastal, FL; Andreoli, SB; Quintana, MIS; Gameiro, MA; Leite, SO; McGrath, J
    Predicting the revolving door phenomenon among patients with schizophrenic, affective disorders and non-organic psychoses
    REVISTA DE SAUDE PUBLICA
    
    F.L. Gastal et al., "Predicting the revolving door phenomenon among patients with schizophrenic, affective disorders and non-organic psychoses", REV SAUDE P, 34(3), 2000, pp. 280-285
49. Buckley, PF
    Comprehensive disease management for schizophrenia
    DRUGS OF TODAY
    
    P.F. Buckley, "Comprehensive disease management for schizophrenia", DRUGS TODAY, 36(5), 2000, pp. 267-280
50. Byrne, M; Browne, R; Mulryan, N; Scully, A; Morris, M; Kinsella, A; Takei, N; McNeil, T; Walsh, D; O'Callaghan, E
    Labour and delivery complications and schizophrenia - Case-control study using contemporaneous labour ward records
    BRITISH JOURNAL OF PSYCHIATRY
    
    M. Byrne et al., "Labour and delivery complications and schizophrenia - Case-control study using contemporaneous labour ward records", BR J PSYCHI, 176, 2000, pp. 531-536
51. Tohen, M; Strakowski, SM; Zarate, C; Hennen, J; Stoll, AL; Suppes, T; Faedda, GL; Cohen, BM; Gebre-Medhin, P; Baldessarini, RJ
    The McLean-Harvard first-episode project: 6-month symptomatic and functional outcome in affective and noneffective psychosis
    BIOLOGICAL PSYCHIATRY
    
    M. Tohen et al., "The McLean-Harvard first-episode project: 6-month symptomatic and functional outcome in affective and noneffective psychosis", BIOL PSYCHI, 48(6), 2000, pp. 467-476
52. McElroy, SL; Keck, PE
    Pharmacologic agents for the treatment of acute bipolar mania
    BIOLOGICAL PSYCHIATRY
    
    S.L. McElroy e P.E. Keck, "Pharmacologic agents for the treatment of acute bipolar mania", BIOL PSYCHI, 48(6), 2000, pp. 539-557
53. Rosenman, S; Korten, A; Medway, J; Evans, M
    Characterising psychosis in the Australian National Survey of Mental Health and Wellbeing Study on Low Prevalence (psychotic) Disorders
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
    
    S. Rosenman et al., "Characterising psychosis in the Australian National Survey of Mental Health and Wellbeing Study on Low Prevalence (psychotic) Disorders", AUST NZ J P, 34(5), 2000, pp. 792-800
54. Ungvari, GS; Mullen, PE
    Reactive psychoses revisited
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
    
    G.S. Ungvari e P.E. Mullen, "Reactive psychoses revisited", AUST NZ J P, 34(3), 2000, pp. 458-467
55. Jablensky, A; McGrath, J; Herrman, H; Castle, D; Gureje, O; Evans, M; Carr, V; Morgan, V; Korten, A; Harvey, C
    Psychotic disorders in urban areas: an overview of the Study on Low Prevalence Disorders
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
    
    A. Jablensky et al., "Psychotic disorders in urban areas: an overview of the Study on Low Prevalence Disorders", AUST NZ J P, 34(2), 2000, pp. 221-236
56. Bayle, FJ; Llorca, PM; Olie, JP; Loo, H
    Anxiety and schizophrenia: review of research
    ANNALES MEDICO-PSYCHOLOGIQUES
    
    F.J. Bayle et al., "Anxiety and schizophrenia: review of research", ANN MED PSY, 158(10), 2000, pp. 741-749
57. Hollis, C
    Adult outcomes of child- and adolescent-onset schizophrenia: Diagnostic stability and predictive validity
    AMERICAN JOURNAL OF PSYCHIATRY
    
    C. Hollis, "Adult outcomes of child- and adolescent-onset schizophrenia: Diagnostic stability and predictive validity", AM J PSYCHI, 157(10), 2000, pp. 1652-1659
58. Howard, L; Leese, M; Thornicroft, G
    Social networks and functional status in patients with psychosis
    ACTA PSYCHIATRICA SCANDINAVICA
    
    L. Howard et al., "Social networks and functional status in patients with psychosis", ACT PSYC SC, 102(5), 2000, pp. 376-385
59. McCrone, P; Menezes, PR; Johnson, S; Scott, H; Thornicroft, G; Marshall, J; Bebbington, P; Kuipers, E
    Service use and costs of people with dual diagnosis in South London
    ACTA PSYCHIATRICA SCANDINAVICA
    
    P. McCrone et al., "Service use and costs of people with dual diagnosis in South London", ACT PSYC SC, 101(6), 2000, pp. 464-472
60. Welham, J; McLachlan, G; Davies, G; McGrath, J
    Heterogeneity in schizophrenia; mixture modelling of age-at-first-admission, gender and diagnosis
    ACTA PSYCHIATRICA SCANDINAVICA
    
    J. Welham et al., "Heterogeneity in schizophrenia; mixture modelling of age-at-first-admission, gender and diagnosis", ACT PSYC SC, 101(4), 2000, pp. 312-317
61. Tarazi, FI; Baldessarini, RJ
    Dopamine D-4 receptors: significance for molecular psychiatry at the millennium
    MOLECULAR PSYCHIATRY
    
    F.I. Tarazi e R.J. Baldessarini, "Dopamine D-4 receptors: significance for molecular psychiatry at the millennium", MOL PSYCHI, 4(6), 1999, pp. 529-538
62. Maziade, M; Roy, MA; Merette, C; Bissonnette, L; Quirion, R; Palmour, R
    Psychopharmacogenetics and psychiatric genetics: similar methodological challenges
    JOURNAL OF PSYCHIATRY & NEUROSCIENCE
    
    M. Maziade et al., "Psychopharmacogenetics and psychiatric genetics: similar methodological challenges", J PSYCH NEU, 24(3), 1999, pp. 211-214
63. Foster, RH; Goa, KL
    Olanzapine - A pharmacoeconomic review of its use in schizophrenia
    PHARMACOECONOMICS
    
    R.H. Foster e K.L. Goa, "Olanzapine - A pharmacoeconomic review of its use in schizophrenia", PHARMACOECO, 15(6), 1999, pp. 611-640
64. Young, SL; Ensing, DS
    Exploring recovery from the perspective of people with psychiatric disabilities
    PSYCHIATRIC REHABILITATION JOURNAL
    
    S.L. Young e D.S. Ensing, "Exploring recovery from the perspective of people with psychiatric disabilities", PSYCH REH J, 22(3), 1999, pp. 219-231
65. Serretti, A; Lattuada, E; Smeraldi, E
    Outcome of affective psychosis
    DEPRESSION AND ANXIETY
    
    A. Serretti et al., "Outcome of affective psychosis", DEPRESS ANX, 10(2), 1999, pp. 50-54
66. Marcus, EL; Vass, A; Zislin, J
    Marked elevation of serum creatine kinase associated with olanzapine therapy
    ANNALS OF PHARMACOTHERAPY
    
    E.L. Marcus et al., "Marked elevation of serum creatine kinase associated with olanzapine therapy", ANN PHARMAC, 33(6), 1999, pp. 697-700
67. McClellan, J; McCurry, C
    Early onset psychotic disorders: Diagnostic stability and clinical characteristics
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY
    
    J. McClellan e C. McCurry, "Early onset psychotic disorders: Diagnostic stability and clinical characteristics", EUR CHILD A, 8, 1999, pp. 13-19
68. Selten, JP; Brown, AS; Moons, KGM; Slaets, JPJ; Susser, ES; Kahn, RS
    Prenatal exposure to the 1957 influenza pandemic and non-affective psychosis in The Netherlands
    SCHIZOPHRENIA RESEARCH
    
    J.P. Selten et al., "Prenatal exposure to the 1957 influenza pandemic and non-affective psychosis in The Netherlands", SCHIZOPHR R, 38(2-3), 1999, pp. 85-91
69. Keck, PE; McElroy, SL; Strakowski, SM
    Schizoaffective disorder: role of atypical antipsychotics
    SCHIZOPHRENIA RESEARCH
    
    P.E. Keck et al., "Schizoaffective disorder: role of atypical antipsychotics", SCHIZOPHR R, 35, 1999, pp. S5-S12
70. McClure, RK
    Backward masking in bipolar affective disorder
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    
    R.K. McClure, "Backward masking in bipolar affective disorder", PROG NEUR-P, 23(2), 1999, pp. 195-206
71. Ghaemi, SN; Goodwin, FK
    Use of atypical antipsychotic agents in bipolar and schizoaffective disorders: Review of the empirical literature
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    
    S.N. Ghaemi e F.K. Goodwin, "Use of atypical antipsychotic agents in bipolar and schizoaffective disorders: Review of the empirical literature", J CL PSYCH, 19(4), 1999, pp. 354-361
72. Torgalsboen, AK
    Full recovery from schizophrenia: the prognostic role of premorbid adjustment, symptoms at first admission, precipitating events and gender
    PSYCHIATRY RESEARCH
    
    A.K. Torgalsboen, "Full recovery from schizophrenia: the prognostic role of premorbid adjustment, symptoms at first admission, precipitating events and gender", PSYCHIAT R, 88(2), 1999, pp. 143-152
73. Zarate, CA; Tohen, M; Narendran, R; Tomassini, EC; McDonald, J; Sederer, M; Madrid, AR
    The adverse effect profile and efficacy of divalproex sodium compared withvalproic acid: A pharmacoepidemiology study
    JOURNAL OF CLINICAL PSYCHIATRY
    
    C.A. Zarate et al., "The adverse effect profile and efficacy of divalproex sodium compared withvalproic acid: A pharmacoepidemiology study", J CLIN PSY, 60(4), 1999, pp. 232-236
74. Ho, BC; Miller, D; Nopoulos, P; Andreasen, NC
    A comparative effectiveness study of risperidone and olanzapine in the treatment of schizophrenia
    JOURNAL OF CLINICAL PSYCHIATRY
    
    B.C. Ho et al., "A comparative effectiveness study of risperidone and olanzapine in the treatment of schizophrenia", J CLIN PSY, 60(10), 1999, pp. 658-663
75. McElroy, SL; Keck, PE; Strakowski, SM
    An overview of the treatment of schizoaffective disorder
    JOURNAL OF CLINICAL PSYCHIATRY
    
    S.L. McElroy et al., "An overview of the treatment of schizoaffective disorder", J CLIN PSY, 60, 1999, pp. 16-21
76. Ereshefsky, L
    Pharmacologic and pharmacokinetic considerations in choosing an antipsychotic
    JOURNAL OF CLINICAL PSYCHIATRY
    
    L. Ereshefsky, "Pharmacologic and pharmacokinetic considerations in choosing an antipsychotic", J CLIN PSY, 60, 1999, pp. 20-30
77. Stahl, SM
    Selecting an atypical antipsychotic by combining clinical experience with guidelines from clinical trials
    JOURNAL OF CLINICAL PSYCHIATRY
    
    S.M. Stahl, "Selecting an atypical antipsychotic by combining clinical experience with guidelines from clinical trials", J CLIN PSY, 60, 1999, pp. 31-41
78. Lillo, SPY
    The madness of "El Quijote"
    REVISTA MEDICA DE CHILE
    
    S.P.Y. Lillo, "The madness of "El Quijote"", REV MED CHI, 127(1), 1999, pp. 89-93
79. Goldstein, JM
    Quetiapine fumarate (Seroquel (R)): A new atypical antipsychotic
    DRUGS OF TODAY
    
    J.M. Goldstein, "Quetiapine fumarate (Seroquel (R)): A new atypical antipsychotic", DRUGS TODAY, 35(3), 1999, pp. 193-210
80. David, AS
    "To see oursels as others see us" - Aubrey Lewis's insight
    BRITISH JOURNAL OF PSYCHIATRY
    
    A.S. David, ""To see oursels as others see us" - Aubrey Lewis's insight", BR J PSYCHI, 175, 1999, pp. 210-216
81. Posener, JA; Schatzberg, AF; Williams, GH; Samson, JA; McHale, NL; Bessette, MP; Schildkraut, JJ
    Hypothalamic-pituitary-adrenal axis effects on plasma homovanillic acid inman
    BIOLOGICAL PSYCHIATRY
    
    J.A. Posener et al., "Hypothalamic-pituitary-adrenal axis effects on plasma homovanillic acid inman", BIOL PSYCHI, 45(2), 1999, pp. 222-228
82. Tohen, M; Sanger, TM; McElroy, SL; Tollefson, GD; Chengappa, R; Daniel, DG; Petty, F; Centorrino, F; Wang, R; Grundy, SL; Greaney, MG; Jacobs, TG; David, SR; Toma, V
    Olanzapine versus placebo in the treatment of acute mania
    AMERICAN JOURNAL OF PSYCHIATRY
    
    M. Tohen et al., "Olanzapine versus placebo in the treatment of acute mania", AM J PSYCHI, 156(5), 1999, pp. 702-709
83. Henderson, C; Phelan, M; Loftus, L; Dall'Agnola, R; Ruggeri, M
    Comparison of patient satisfaction with community-based vs. hospital psychiatric services
    ACTA PSYCHIATRICA SCANDINAVICA
    
    C. Henderson et al., "Comparison of patient satisfaction with community-based vs. hospital psychiatric services", ACT PSYC SC, 99(3), 1999, pp. 188-195
84. Slade, M; Leese, M; Taylor, R; Thornicroft, G
    The association between needs and quality of life in an epidemiologically representative sample of people with psychosis
    ACTA PSYCHIATRICA SCANDINAVICA
    
    M. Slade et al., "The association between needs and quality of life in an epidemiologically representative sample of people with psychosis", ACT PSYC SC, 100(2), 1999, pp. 149-157
85. Sutherby, K; Szmukler, GI; Halpern, A; Alexander, M; Thornicroft, G; Johnson, C; Wright, S
    A study of 'crisis cards' in a community psychiatric service
    ACTA PSYCHIATRICA SCANDINAVICA
    
    K. Sutherby et al., "A study of 'crisis cards' in a community psychiatric service", ACT PSYC SC, 100(1), 1999, pp. 56-61
86. BEVER KA; PERRY PJ
    OLANZAPINE - A SEROTONIN-DOPAMINE-RECEPTOR ANTAGONIST FOR ANTIPSYCHOTIC THERAPY
    American journal of health-system pharmacy
    
    K.A. Bever e P.J. Perry, "OLANZAPINE - A SEROTONIN-DOPAMINE-RECEPTOR ANTAGONIST FOR ANTIPSYCHOTIC THERAPY", American journal of health-system pharmacy, 55(10), 1998, pp. 1003-1016
87. AMORIM P; LECRUBIER Y; WEILLER E; HERGUETA T; SHEEHAN D
    DSM-III-R PSYCHOTIC DISORDERS - PROCEDURAL VALIDITY OF THE MINI INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW (MINI) - CONCORDANCE AND CAUSES FOR DISCORDANCE WITH THE CIDI
    European psychiatry
    
    P. Amorim et al., "DSM-III-R PSYCHOTIC DISORDERS - PROCEDURAL VALIDITY OF THE MINI INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW (MINI) - CONCORDANCE AND CAUSES FOR DISCORDANCE WITH THE CIDI", European psychiatry, 13(1), 1998, pp. 26-34
88. CUESTA MJ; PERALTA V; ZARZUELA A
    ILLNESS DURATION AND NEUROPSYCHOLOGICAL IMPAIRMENTS IN SCHIZOPHRENIA
    Schizophrenia research
    
    M.J. Cuesta et al., "ILLNESS DURATION AND NEUROPSYCHOLOGICAL IMPAIRMENTS IN SCHIZOPHRENIA", Schizophrenia research, 33(3), 1998, pp. 141-150
89. SANDERS RD; FORMAN SD; PIERRI JN; BAKER RW; KELLEY ME; VANKAMMEN DP; KESHAVAN MS
    INTERRATER RELIABILITY OF THE NEUROLOGICAL EXAMINATION IN SCHIZOPHRENIA
    Schizophrenia research
    
    R.D. Sanders et al., "INTERRATER RELIABILITY OF THE NEUROLOGICAL EXAMINATION IN SCHIZOPHRENIA", Schizophrenia research, 29(3), 1998, pp. 287-292
90. KUMRA S; WIGGS E; KRASNEWICH D; MECK J; SMITH ACM; BEDWELL J; FERNANDEZ T; JACOBSEN LK; LENANE M; RAPOPORT JL
    BRIEF REPORT - ASSOCIATION OF SEX-CHROMOSOME ANOMALIES WITH CHILDHOOD-ONSET PSYCHOTIC DISORDERS
    Journal of the American Academy of Child and Adolescent Psychiatry
    
    S. Kumra et al., "BRIEF REPORT - ASSOCIATION OF SEX-CHROMOSOME ANOMALIES WITH CHILDHOOD-ONSET PSYCHOTIC DISORDERS", Journal of the American Academy of Child and Adolescent Psychiatry, 37(3), 1998, pp. 292-296
91. FRYE MA; KETTER TA; ALTSHULER LL; DENICOFF K; DUNN RT; KIMBRELL TA; CORALOCATELLI G; POST RM
    CLOZAPINE IN BIPOLAR DISORDER - TREATMENT IMPLICATIONS FOR OTHER ATYPICAL ANTIPSYCHOTICS
    Journal of affective disorders
    
    M.A. Frye et al., "CLOZAPINE IN BIPOLAR DISORDER - TREATMENT IMPLICATIONS FOR OTHER ATYPICAL ANTIPSYCHOTICS", Journal of affective disorders, 48(2-3), 1998, pp. 91-104
92. KECK PE; MCELROY SL; STRAKOWSKI SM
    ANTICONVULSANTS AND ANTIPSYCHOTICS IN THE TREATMENT OF BIPOLAR DISORDER
    The Journal of clinical psychiatry
    
    P.E. Keck et al., "ANTICONVULSANTS AND ANTIPSYCHOTICS IN THE TREATMENT OF BIPOLAR DISORDER", The Journal of clinical psychiatry, 59, 1998, pp. 74-81
93. MELTZER HY; CASEY DE; GARVER DL; LASAGNA L; MARDER SR; MASAND PS; MILLER D; PICKAR D; TANDON R
    ATYPICAL ANTIPSYCHOTICS FOR TREATMENT OF DEPRESSION IN SCHIZOPHRENIA AND AFFECTIVE-DISORDERS
    The Journal of clinical psychiatry
    
    H.Y. Meltzer et al., "ATYPICAL ANTIPSYCHOTICS FOR TREATMENT OF DEPRESSION IN SCHIZOPHRENIA AND AFFECTIVE-DISORDERS", The Journal of clinical psychiatry, 59, 1998, pp. 41-45
94. TOHEN M; ZARATE CA
    ANTIPSYCHOTIC AGENTS AND BIPOLAR DISORDER
    The Journal of clinical psychiatry
    
    M. Tohen e C.A. Zarate, "ANTIPSYCHOTIC AGENTS AND BIPOLAR DISORDER", The Journal of clinical psychiatry, 59, 1998, pp. 38-49
95. JAAR E; GOMEZ A; ORELLANA G; NUNEZ C; MONTINO O; LOLAS F
    STUDY OF FEMALE SUICIDE ATTEMPTERS - A 5 YEARS FOLLOW-UP
    Revista Medica de Chile
    
    E. Jaar et al., "STUDY OF FEMALE SUICIDE ATTEMPTERS - A 5 YEARS FOLLOW-UP", Revista Medica de Chile, 126(8), 1998, pp. 924-929
96. MALHOTRA S; VARMA VK; MISRA AK; DAS S; WIG NN; SANTOSH PJ
    ONSET OF ACUTE PSYCHOTIC STATES IN INDIA - A STUDY OF SOCIODEMOGRAPHIC, SEASONAL AND BIOLOGICAL FACTORS
    Acta psychiatrica Scandinavica
    
    S. Malhotra et al., "ONSET OF ACUTE PSYCHOTIC STATES IN INDIA - A STUDY OF SOCIODEMOGRAPHIC, SEASONAL AND BIOLOGICAL FACTORS", Acta psychiatrica Scandinavica, 97(2), 1998, pp. 125-131
97. MENEZES PR; RODRIGUES LC; MANN AH
    PREDICTORS OF CLINICAL AND SOCIAL OUTCOMES AFTER HOSPITALIZATION IN SCHIZOPHRENIA
    European archives of psychiatry and clinical neuroscience
    
    P.R. Menezes et al., "PREDICTORS OF CLINICAL AND SOCIAL OUTCOMES AFTER HOSPITALIZATION IN SCHIZOPHRENIA", European archives of psychiatry and clinical neuroscience, 247(3), 1997, pp. 137-145
98. GRAWE RW; PEDERSEN PB; WIDEN JH
    CHANGES IN PREVALENCE AND COMORBIDITY IN A TOTAL POPULATION OF PATIENTS WITH PSYCHOTIC DISORDERS IN NORWEGIAN PSYCHIATRIC-HOSPITALS
    Nordic journal of psychiatry
    
    R.W. Grawe et al., "CHANGES IN PREVALENCE AND COMORBIDITY IN A TOTAL POPULATION OF PATIENTS WITH PSYCHOTIC DISORDERS IN NORWEGIAN PSYCHIATRIC-HOSPITALS", Nordic journal of psychiatry, 51(2), 1997, pp. 127-132
99. ZWIL AS; POMERANTZ A
    TRANSIENT POSTICTAL PSYCHOSIS ASSOCIATED WITH A COURSE OF ECT
    Convulsive therapy
    
    A.S. Zwil e A. Pomerantz, "TRANSIENT POSTICTAL PSYCHOSIS ASSOCIATED WITH A COURSE OF ECT", Convulsive therapy, 13(1), 1997, pp. 32-36
100. GHAEMI SN; SACHS GS; BALDASSANO CF; TRUMAN CJ
     ACUTE TREATMENT OF BIPOLAR DISORDER WITH ADJUNCTIVE RISPERIDONE IN OUTPATIENTS
     Canadian journal of psychiatry
     
     S.N. Ghaemi et al., "ACUTE TREATMENT OF BIPOLAR DISORDER WITH ADJUNCTIVE RISPERIDONE IN OUTPATIENTS", Canadian journal of psychiatry, 42(2), 1997, pp. 196-199